News

Tagworks reports that the scope of its proprietary click-to-release reaction can be expanded from the cleavage of carbamates to ethers, potentially allowing more drug types to be released from their click-cleavable ADCs. https://doi.org/10.1002/anie.201800402

In mouse models of ovarian and aggressive colon cancer, Tagworks Pharmaceuticals has demonstrated the potent antitumour effect of the company's 'click-to-release' bioorthogonal chemistry approach. The results are published in the journal Nature Communications Raffaella Rossin, et al., Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity …

Tagworks' CEO Marc Robillard is one of the speakers at Antibody Engineering & Therapeutics Europe 2018 in Amsterdam from 5-7 June. Marc will present the company's latest results on "Click chemistry-triggered drug release from a tumor-bound ADC" on Thursday 7 June. His lecture is part of a session on "Novel …

Tagworks CEO Marc Robillard talks about entrepreneurship in the life sciences field and shares his experiences as co-founder of Tagworks Pharmaceuticals during the InnoBoot Session: Business meets Science at the StartupDelta Summit on Thursday April 19, 2018, in Arnhem, the Netherlands. More information on the event: https://startupdeltasummit.com/overdesummit/

Tagworks CSO Raffaella Rossin presents the company's latest research achievements on 'In vivo click chemistry' at the 19th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR) in Groningen, the Netherlands on Friday, April 6, 2018. More information: http://www.esrr.info/welcome-address/

Tagworks is featured in a BioCentury article on the state of the art and clinical prospects of in vivo click chemistry. https://www.biocentury.com/bc-innovations/tools-techniques/2017-06-15/new-use-click-chemistry-vivo-can-trigger-rapid-drug-?kwh=clear%3C%7C%3Eclears

Tagworks CEO Marc Robillard will present at and co-chair the session on 'Bioorthogonal and Click Chemistry for Molecular Imaging' on Sunday October 21, 13:00-16:00, during the 30th Annual Conference of the European Association of Nuclear Medicine (EANM), October 21-25, 2017, Vienna, Austria. More information on EANM'17: http://eanm17.eanm.org

Tagworks' Research Manager Raffaella Rossin participates in the 22nd International Symposium on Radiopharmaceutical Sciences (iSRS) in Dresden, Germany, from May 14-19, 2017 More information on the conference: http://isrs2017.org

8-9 November 2017, 3rd Antibodies and Bio Therapeutics Congress, Las Vegas

10-11 January 2017, 'Engineering for clinical success': CHI's 4th annual Antibody Drug Conjugates conference, San Diego